Apellis Pharmaceuticals
APLS
APLS
92 hedge funds and large institutions have $782M invested in Apellis Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 28 reducing their positions, and 17 closing their positions.
Holders
92
Holders Change
-3
Holders Change %
-3.16%
% of All Funds
1.99%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
14
Increased
35
Reduced
28
Closed
17
Calls
$1.46M
Puts
$1.46M
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$75.6M |
2 |
O
2
OrbiMed
New York
|
$34.4M |
3 |
3
Morgan Stanley
New York
|
$24.3M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$18.4M |
5 |
5
Millennium Management
New York
|
$37.6M |